While weight-loss injections are being pushed as the ultimate fix for obesity, they come with a slew of unpleasant side effects that no one’s talking about loudly enough. Nausea, vomiting, diarrhea, constipation, and abdominal pain are particularly common. More serious risks include eye damage and pancreas problems. And as this latest study now confirms, if patients stop having the injections, most or all of the weight they have lost will likely come back. At a cost of around US$1,000 per month per patient, the pharma industry has a vested interest in people becoming dependent on these treatments.
Far from being the game-changer that they are being promoted as, weight-loss drugs are just the latest overhyped pharma fad. It would therefore be naïve to expect them to solve the global obesity problem anytime soon. Instead, they’re simply another dangerous distraction that puts more money in pharma pockets and avoids addressing real, long-term health solutions.
To learn more about the weight-loss industry, see this article by Dr. Aleksandra Niedzwiecki on our website.
U.S. Food and Drug Administration Faces Legal Challenge Over Blocked Nutrient Health Claims
January 16, 2026Diabetes Costs the Global Economy Trillions, Says Study
January 16, 2026People Who Stop Taking Weight-Loss Jabs Regain Weight in Under Two Years, Study Reveals
News
People who stop taking weight-loss jabs regain all the weight originally lost in under two years, significantly faster than those on any other weight-loss plan, according to a landmark study.
[Source: theguardian.com]
[Image source: Freepik]
Comment
While weight-loss injections are being pushed as the ultimate fix for obesity, they come with a slew of unpleasant side effects that no one’s talking about loudly enough. Nausea, vomiting, diarrhea, constipation, and abdominal pain are particularly common. More serious risks include eye damage and pancreas problems. And as this latest study now confirms, if patients stop having the injections, most or all of the weight they have lost will likely come back. At a cost of around US$1,000 per month per patient, the pharma industry has a vested interest in people becoming dependent on these treatments.
Far from being the game-changer that they are being promoted as, weight-loss drugs are just the latest overhyped pharma fad. It would therefore be naïve to expect them to solve the global obesity problem anytime soon. Instead, they’re simply another dangerous distraction that puts more money in pharma pockets and avoids addressing real, long-term health solutions.
To learn more about the weight-loss industry, see this article by Dr. Aleksandra Niedzwiecki on our website.
Dr. Rath Health Foundation
Related posts
Claimants in Johnson & Johnson Talcum Powder Case Rise to 7,000
Read more